CME
A Look at the Numbers: Cost of Durable Treatments in Retinal Disease
Host: Jayanth Sridhar, MD Host: Sabin Dang, MD The approval of new, more durable treatments is an exciting development for the management of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), but how do the